August 11, 2026 AC Immune Receives FDA Fast Track Designation for Anti-Alpha-synuclein Active Immunotherapy, ACI-7104, to Treat Early Parkinson’s Disease (PD)
August 11, 2026 BusRight Proudly Named Among America’s Fastest-Growing Private Companies on the 2026 Inc. 5000
August 11, 2026 Asahi Expands Packaging Capabilities with High-Speed Bottling Line at Octopi Facility
August 11, 2026 C4 Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights
